Lutetium-(177Lu)-oxodotreotideHypothyroidism

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1984卷 / 1期

关键词：

D O I：

10.1007/s40278-023-50544-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：313 / 313

相关论文

共 50 条

[41] Lutetium-(177lu)-oxodotreotideLack of efficacy: case report
Reactions Weekly, 2023, 1950 (1) : 247 - 247
[42] Lutetium-(177lu)-oxodotreotideAnaemia and thrombocytopenia: case report
Reactions Weekly, 2021, 1875 (1) : 198 - 198
[43] Lutetium-(177Lu)-vipivotide-tetraxetanHaematological toxicity
Reactions Weekly, 2024, 1991 (1) : 133 - 133
[44] Lutetium-(177lu)-oxodotreotideSmall bowel obstruction: case report
Reactions Weekly, 2022, 1935 (1) : 247 - 247
[45] Lutetium-(177lu)-oxodotreotideVarious toxicities: 4 case reports
Reactions Weekly, 2020, 1821 (1) : 159 - 159
[46] Lutetium-(177lu)-oxodotreotideBowel obstruction: 5 case reports
Reactions Weekly, 2021, 1881 (1) : 153 - 153
[47] Lutetium-(177lu)-oxodotreotideVarious toxicities: 5 case reports
Reactions Weekly, 2019, 1754 (1) : 223 - 223
[48] Lutetium-(177lu)-oxodotreotideTuberculous arthritis flaring: case report
Reactions Weekly, 2022, 1930 (1) : 332 - 332
[49] Lutetium-(177Lu)-vipivotide-tetraxetanThrombocytopenia: case report
Reactions Weekly, 2024, 2022 (1) : 164 - 164
[50] Lutetium-(177Lu)-oxodotreotide/VandetanibTreatment failure: case report
Reactions Weekly, 2025, 2052 (1) : 245 - 245

← 1 2 3 4 5 →